Presentation TCT 2017

Should a Hybrid Revascularization Strategy for Left Main Disease Be Considered?

Presenter: John D. Puskas

November 01, 2017

REGISTER for free or LOG IN to view this content

Should a Hybrid Revascularization Strategy for Left Main Disease Be Considered?

Coronary

Presentation

TCT 2017

Up Next

Presentation TCT 2017

DCB Architecture: Technical Features Determining Long-term Safety and Efficacy

Presenter: Juan F. Granada

November 01, 2017

More slides +

Presentation TCT 2017

Long-Term Data With Standard-Dose DCB Technologies (IN.PACT SFA and the Consequent Trial)

Presenter: Peter A. Schneider

November 01, 2017

Presentation TCT 2017

Long-term Data With Lower-Dose DCB Technologies (LEVANT, ILLUMINATE, RANGER)

Presenter: Mitchell Weinberg

November 01, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.